Company Reports

Advantest’s June-quarter results were again driven by artificial intelligence demand. Revenue rose 39% year on year and operating margin reached 51.7%, record highs. The firm raised full-year revenue and operating profit guidance by 21% and 35%, respectively.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.

Advantest's shares have fallen approximately 10% since the company reported 41% year-on-year revenue growth and a 67% gross margin for the March quarter. Against this backdrop, we reassessed the company's growth prospects.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.

Advantest's March-quarter revenue exceeded guidance by more than 20%, driven by robust demand for artificial intelligence. For fiscal 2026 (ending March 2027), the company guides revenue growth of 26% based on the expectation that the system-on-chip, or SoC, tester market will grow by 32% in 2026.

Following meetings with companies regarding December-quarter results, we revised our earnings forecasts for Advantest and Ajinomoto. We note that the technological hurdles for semiconductor packaging will increase significantly as artificial intelligence architectures evolve.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.

Advantest's sales for the December quarter increased 26% year over year, driven by robust investment in artificial intelligence. The company raised its fiscal 2025 (ending March 2026) sales guidance by 12.6%, surpassing its updated medium-term plan announced just three months prior.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.

Advantest's sales for the September quarter were JPY 263 billion, up 38% year over year, and exceeded the guidance of JPY 237 billion due to better demand. Accordingly, the company raised its full-year sales guidance for fiscal 2025 (ending March 2026) to JPY 950 billion from JPY 835 billion.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.

In the June quarter, Advantest's sales and operating income increased by 90% and about fourfold, respectively, year over year. The company raised its sales guidance for fiscal 2025 (ending in March 2026) by 10.6%, indicating 52% growth in the first half, but a 26% decline in the second half.

We are initiating coverage of Advantest, the world's leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player, Teradyne.

Advantest is the world’s leading supplier of automated test equipment, or ATE, controlling over 80% of the market together with the second player Teradyne.